What Stripe, PayPal and Square publish about research-only peptide businesses

A published policy is not a decision about your account

Each processor publishes rules about kinds of businesses and products. A rule tells you which questions matter for your catalog. The decision about one account is made separately, by the processor, against the business it actually reviews.

The documents say so in their own terms. Stripe's FAQ says every account is reviewed at activation, and Stripe's list says approval for a restricted category may not be available, is specific to a service offer, and can change or be revoked. PayPal's Acceptable Use Policy sends preapproval and new-account questions to PayPal's sales team. Square's Payment Terms let Square ask for evidence about the business and its identity, and say that refusing can lead to suspension or termination.

This page compares what each document said when it was checked on 2026-10-06. It keeps the processor's words, Prism's plain reading of them, and the questions they leave open apart. The linked documents control and can change, and Prism does not speak for any of these companies.

Stripe: research peptides addressed, with conditions

Stripe's Prohibited and Restricted Businesses page, read with the United States (English) country selector and showing a last-updated date of September 22, 2026, lists incorrectly labeled research chemicals among its prohibited categories, as well as nutraceuticals and pseudo-pharmaceuticals that are unsafe or make harmful claims. Its restricted categories require extra due diligence. Its entry for pharmaceuticals, medical devices and telemedicine covers online pharmacies and prescription-only products. The same page prohibits misleading identity or business information, products not disclosed in the application, and undisclosed merchants, and it requires the merchant to notify Stripe when business information changes.

Stripe's Prohibited and Restricted Businesses List FAQs page showed no update date. It says every account is reviewed at activation. In its pharmaceutical and peptides section, the answer to whether a business that is not a pharmacy may sell peptides says Stripe supports many peptides, subject to limitations, and that prescription-only peptides come with pharmacy and preapproval conditions. The FAQ describes instances without prior approval, including research peptides when preventive measures keep them from nonresearch purchasers. It says a peptide sold with no purpose specified is assumed to be for human consumption.

Prism's reading: the list does not publish a blanket prohibition on properly labeled research peptides. It prohibits research chemicals that are labeled incorrectly, and the FAQ makes the research-purpose case depend on preventive measures and on the activation review. The FAQ's general text and its peptide answer have to be read together; neither document alone gives the whole picture.

Left open: the FAQ does not set out one exhaustive list of preventive measures, and it does not say whether any particular store's controls meet the condition. Stripe's review, not the public list, applies these categories to a particular product page. The Stripe reading in the related guides goes through each provision and what it does not decide.

PayPal: prior approval for listed activities; research peptides not named

PayPal's US Acceptable Use Policy shows a last-updated date of October 29, 2022, and was read on 2026-10-06. It prohibits using PayPal for illegal activity and for transactions involving narcotics, steroids, certain controlled substances or other products that present a risk to consumer safety, and drug paraphernalia. It requires PayPal's prior approval for listed activities, including prescription products and dispensing, telemedicine, and specified medical items and services, and that list is not exhaustive. A table in the policy sends preapproval and new-account questions to PayPal's sales team and general questions to its Help Center.

Prism's reading: the policy, as read, does not name research-only peptides. That absence is not authorization. It also does not mean PayPal follows Stripe's research-purpose wording, which is Stripe's alone. The policy does not answer whether PayPal would treat a particular research-only catalog as prohibited, as needing approval, or as neither.

Left open: PayPal's User Agreement and its help pages on account limitations were not part of this reading, so this page makes no statement about PayPal holds, limitations, closures or appeals. For an approval question, the policy's own direction is PayPal's sales team. Put the question in writing, describe the actual catalog, and keep the reply.

Square: pharmacy and high-risk exclusions, verification and reserves

Square's US Payment Terms show a last-updated date of July 30, 2026, apply to all Square sellers from that date, and cover the fifty states and the District of Columbia. The page places gray annotations beside the terms and says those annotations are not legally operative, so this reading relies on the terms themselves.

The prohibited-business section includes illegal goods and activity, internet, mail and telephone pharmacies and pharmacy referral services, and high-risk products and services. Section 8, Underwriting and Identity Verification, lets Square request evidence about the business and its identity, including supplier invoices, a license and identification, and says that refusing can lead to suspension or termination. Section 14, Reserve for Holding Funds, allows Square to delay or withhold payouts and to hold a reserve based on potential losses and risk, and the amount can change. The terms also require the actual business to be named accurately.

Prism's reading: the terms, as read, do not name research-only peptides, and absence from the list is not acceptance. Stripe's research-purpose wording is Stripe's and does not carry over to Square. A seller should expect that Square can ask for supplier invoices, a license and identification, and that payouts can be delayed or held in reserve.

Left open: this reading does not establish a fixed hold period or any review outcome. Square's General Terms and its help articles on deactivation were not part of this reading, so this page makes no statement about Square's deactivation reasons or appeal process.

What these documents do not decide about your business

None of these documents approves or refuses a catalog. Stripe's FAQ ties the research-purpose case to preventive measures without one exhaustive list of them. PayPal's policy and Square's terms, as read, are silent on research-only peptides, and that silence does not answer the question either way.

The reading uses the United States versions of Stripe's list, PayPal's policy and Square's terms, and Stripe's support pages as they appeared on the same date. It does not describe any other country's version.

This page does not estimate approval odds or review times. A displayed update date is the processor's own date, not the date the page was checked. PayPal's 2022 date belongs to the policy; the policy itself was read in October 2026.

Prepare the facts, then ask the processor in writing

Start from the business you actually operate: the legal entity and public brand, where it operates and ships from, the products on the live catalog, how orders are taken, and the purpose the product pages state. Compare those facts with each row of the worksheet below, and note where your pages and your application match or differ.

Then ask the processor in writing about that business. Name the provision you are asking about, and keep the reply with its date, its author and any condition it attaches. A sentence saying a category can be considered is not an approval of the account.

If Stripe has already rejected or closed an account, its own documents give the next step. Stripe's FAQ says that if prohibited items have been removed after a rejection, the merchant can reply to the notice with a link to the page showing the removal, or contact support. Stripe's account-closure article says a closure notification goes to the registered email with a reason, alongside a red banner in the Dashboard, and that a business that believes it was misunderstood or miscategorized can use the form linked in that email, which points to the Dashboard for more information about the business. That is a review path, not a promise of reinstatement.

Do not relabel products, leave live products out of the description, or process through another business's account to fit a policy. Stripe's list prohibits misleading business information, undisclosed products and undisclosed merchants, and any processor can compare your description with the live site.

Reading note

Checked 2026-10-06. The dates below are the dates each page displayed, not check dates. PayPal's User Agreement and account-limitation help, and Square's General Terms and deactivation help, were not read for this version and are not relied on. When a processor changes a document, this reading is out of date until the document is read again; the linked document controls.

• Stripe, Prohibited and Restricted Businesses: last updated September 22, 2026.
• Stripe, Prohibited and Restricted Businesses List FAQs: no update date shown.
• Stripe, support article on why an account was closed: no update date shown.
• PayPal, Acceptable Use Policy (US): last updated October 29, 2022.
• Square, Payment Terms (US): last updated July 30, 2026.

Processor policy reading record

One row for each document provision used on this page, as read on 2026-10-06. Compare it with your live catalog, your site and what you told the processor, and note the processor's written reply when you have one. Leave a row blank until you can fill it from your own records.

Worksheet entries are not submitted by Prism’s worksheet and are not saved by the site. Use record types, availability, anonymized observations, or match/mismatch results. Do not enter government identifiers, customer names or addresses, customer messages, receipt-access links, card or bank details, passwords, or keys. Send sensitive documents only through the provider’s verified secure channel.

These are temporary notes. Leaving or reloading this page may clear them. Worksheet entries are not sent automatically. If you copy notes into the consultation message and submit the form, Prism receives them as part of your request.